Patents by Inventor Takashi Naka
Takashi Naka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10752575Abstract: The present invention relates to a production method of 4-alkoxy-3-trifluoromethylbenzyl alcohol at a high conversion ratio, which can strictly suppress production of a byproduct by using DIBAL as a reducing agent.Type: GrantFiled: July 28, 2017Date of Patent: August 25, 2020Assignee: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Makoto Kawano, Takashi Naka, Mitsuharu Nakamura, Hisao Takayanagi
-
Patent number: 10651486Abstract: A fuel cell system includes a fuel cell stack configured to generate power according to a load, a fuel tank configured to store fuel gas, a pressure regulating valve configured to regulate a pressure of the fuel gas supplied from the fuel tank to the fuel cell stack, a purge valve configured to purge the fuel gas discharged from the fuel cell stack and a controller for controlling the system. The controller includes a pulsating unit configured to cause a fuel gas pressure of the fuel cell stack to pulsate, and a pressure increasing rate setting unit configured to set a pressure increasing rate of the pulsation of the fuel gas pressure according to an operating state.Type: GrantFiled: March 15, 2013Date of Patent: May 12, 2020Assignee: Nissan Motor Co., Ltd.Inventors: Susumu Maeshima, Keigo Ikezoe, Yasushi Ichikawa, Takahiro Fujii, Takashi Naka, Daigo Iwasaki
-
Patent number: 10622965Abstract: A surface acoustic wave device assembly includes a collective board, first circuit portions provided on the collective board and respectively including first hot terminals and first ground terminals, a second circuit portion provided on the collective board and including second hot terminals and second ground terminals, and a power supply wiring provided on the collective board so as to surround the periphery of the first circuit portions and the second circuit portion. The first circuit portions include surface acoustic wave devices defining band pass filters. The second circuit portion defines a band pass filter. The first ground terminals and first hot terminals, and the second ground terminal are connected to the power supply wiring, the second hot terminals are not connected to the power supply wiring, and pass bands of the surface acoustic wave devices and a pass band of the band pass filter defined by the second circuit portion are the same or substantially the same.Type: GrantFiled: July 17, 2017Date of Patent: April 14, 2020Assignee: Murata Manufacturing Co., Ltd.Inventors: Toru Takeshita, Seiji Kai, Takashi Naka, Motoji Tsuda, Mitsuyoshi Hira
-
Publication number: 20190161432Abstract: The present invention relates to a production method of 4-alkoxy-3-trifluoromethylbenzyl alcohol at a high conversion ratio, which can strictly suppress production of a byproduct by using DIBAL as a reducing agent.Type: ApplicationFiled: July 28, 2017Publication date: May 30, 2019Applicant: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Makoto KAWANO, Takashi NAKA, Mitsuharu NAKAMURA, Hisao TAKAYANAGI
-
Publication number: 20170317659Abstract: A surface acoustic wave device assembly includes a collective board, first circuit portions provided on the collective board and respectively including first hot terminals and first ground terminals, a second circuit portion provided on the collective board and including second hot terminals and second ground terminals, and a power supply wiring provided on the collective board so as to surround the periphery of the first circuit portions and the second circuit portion. The first circuit portions include surface acoustic wave devices defining band pass filters. The second circuit portion defines a band pass filter. The first ground terminals and first hot terminals, and the second ground terminal are connected to the power supply wiring, the second hot terminals are not connected to the power supply wiring, and pass bands of the surface acoustic wave devices and a pass band of the band pass filter defined by the second circuit portion are the same or substantially the same.Type: ApplicationFiled: July 17, 2017Publication date: November 2, 2017Inventors: Toru TAKESHITA, Seiji KAI, Takashi NAKA, Motoji TSUDA, Mitsuyoshi HIRA
-
Publication number: 20150056531Abstract: A fuel cell system includes a fuel cell stack configured to generate power according to a load, a fuel tank configured to store fuel gas, a pressure regulating valve configured to regulate a pressure of the fuel gas supplied from the fuel tank to the fuel cell stack, a purge valve configured to purge the fuel gas discharged from the fuel cell stack and a controller for controlling the system. The controller includes a pulsating unit configured to cause a fuel gas pressure of the fuel cell stack to pulsate, and a pressure increasing rate setting unit configured to set a pressure increasing rate of the pulsation of the fuel gas pressure according to an operating state.Type: ApplicationFiled: March 15, 2013Publication date: February 26, 2015Inventors: Susumu Maeshima, Keigo Ikezoe, Yasushi Ichikawa, Takahiro Fujii, Takashi Naka, Daigo Iwasaki
-
Patent number: 7928088Abstract: The present invention provides an agent for promoting human Th1 cell differentiation and an agent for suppressing human Th2 cell differentiation, comprising lipoarabinomannans and/or lipomannans derived from BCG cell bodies. The agent of the present invention is useful as a prophylactic/therapeutic agent for cancers and the like, and also as a therapeutic agent for allergic diseases such as pollinosis.Type: GrantFiled: November 14, 2007Date of Patent: April 19, 2011Assignees: Riken, Japan BCG LaboratoryInventors: Masaru Taniguchi, Toshinori Nakayama, Ikuya Yano, Takashi Naka
-
Publication number: 20080182818Abstract: The present invention provides an agent for promoting human Th1 cell differentiation and an agent for suppressing human Th2 cell differentiation, comprising lipoarabinomannans and/or lipomannans derived from BCG cell bodies. The agent of the present invention is useful as a prophylactic/therapeutic agent for cancers and the like, and also as a therapeutic agent for allergic diseases such as pollinosis.Type: ApplicationFiled: November 14, 2007Publication date: July 31, 2008Applicants: RIKEN, JAPAN BCG LABORATORYInventors: Masaru TANIGUCHI, Toshinori NAKAYAMA, Ikuya YANO, Takashi NAKA
-
Publication number: 20070270589Abstract: Object: To offer novel quinazoline derivatives, which are useful as intermediates in the production of agents for the treatment and prevention of cancer, and an industrially useful method for manufacture of the same. Means: The quinazoline derivative represented by general formula (I) below: (in the formula, each of the symbols is the same as described in the specification) or a salt thereof, or a hydrate or solvate thereof, and a method for using the same to produce novel quinazoline derivatives.Type: ApplicationFiled: November 26, 2004Publication date: November 22, 2007Applicant: MITSUBISHI PHARMA CORPORATIONInventors: Hiroshi Iwamura, Takashi Naka
-
Patent number: 6576172Abstract: A processed material in which a fibrous binder is mixed with chip-like solid matters such as soft urethane foam is quickly injected into a preform mold having a flat molding surface with a uniform filling density, and then fed to a main mold having a molding surface whose shape corresponds to that of a sound-proof product to be formed, so that main molding is performed under sufficient pressure and heat. With the main molding carried out after the preform molding, it is possible to manufacture sound-proof products of excellent quality.Type: GrantFiled: August 14, 2000Date of Patent: June 10, 2003Assignee: Toyoda Boshoku CorporationInventors: Toshiyuki Ario, Takashi Naka, Junichi Hishida, Tetsuyasu Akita, Masaru Suzuki, Yasushi Tsujita, Takuji Kajihara